Shanghai’s Cutia Therapeutics, has made a strategic 2 million Euro investment in the Israel’s Hairstetics (see here previously). Hairstetics has developed an award-winning, pioneering medical device for the minimally invasive implantation of synthetic hair fibers, designed to address female alopecia.